AstraZeneca plc (AZN) Ordinary US$0.25

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
AstraZeneca's Baxdrostat hits Phase III endpoint in resistant hypertension
7 October 2025 07:27
(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Baxdrostat had met its primary endpoint in the Bax24 Phase III trial, delivering a "statistically significant and clinically meaningful...
-
London midday: Stocks mixed with French and US fiscal impasses in focus
6 October 2025 11:13
(Sharecast News) - Stocks in London were trading on a mixed note around the midday mark, but had stabilised despite news of the French Prime Minister's resignation after just a month on the job.
-
London midday: UK stocks keep grinding towards year's highs
3 October 2025 11:15
(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the...
-
Trump's MFN deal with Pfizer could be bellwether for pharma sector, says JPM
1 October 2025 09:26
(Sharecast News) - US President Donald Trump's 'Most Favoured Nation' deal with Pfizer could be a bellwether for the pharmaceutical sector and reassure investors over a broadly manageable...
-
AstraZeneca to list in New York, retain London listing
29 September 2025 09:24
(Sharecast News) - Anglo-Swedish drugs giant AstraZeneca is to list directly on the New York Stock Exchange, it was announced on Monday.
-
Trump to impose tariffs of 100% on branded drug imports
26 September 2025 07:53
(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war.
-
EU approves AstraZeneca's Tezspire to treat nasal conditions
22 September 2025 07:06
(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal...
-
London close: Stocks mixed ahead of central bank decisions
15 September 2025 17:51
(Sharecast News) - London stocks ended mixed on Monday as investors adopted a cautious stance ahead of a series of major central bank policy decisions due later this week.
-
AstraZeneca to pause £200m Cambridge investment, shares slump
15 September 2025 08:58
(Sharecast News) - AstraZeneca slumped on Monday after saying it was pausing plans to invest £200m at its Cambridge research site.
-
London close: Stocks fall on Trump's latest tariffs, US jobs data
1 August 2025 17:37
(Sharecast News) - London stocks ended the week lower on Friday as investors reacted to a fresh wave of US tariffs and disappointing economic data from the United States.
-
London close: Stocks mixed on corporate updates, trade developments
29 July 2025 16:28
(Sharecast News) - London stocks ended Tuesday on a mixed note as a wave of corporate results kept investors busy and market participants continued to assess the implications of the recent US-EU trade deal.
-
Astrazeneca H1 gross profits up 10pc as 'strong growth momentum' continues
29 July 2025 07:09
(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that "strong growth momentum" had continued in H1, with "excellent R&D pipeline delivery" in the year-to-date.
Company announcements Announcements
-
Baxdrostat met primary endpoint in Bax24 Ph3 trial
7 October 2025 07:00
AstraZeneca
-
Datroway improved OS and PFS in TROPION-Breast02
6 October 2025 07:30
AstraZeneca
-
Total Voting Rights
1 October 2025 15:00
AstraZeneca
-
Enhertu improved IDFS in early BC in DB-05
29 September 2025 07:30
AstraZeneca
-
AZN harmonises listing structure
29 September 2025 07:00
AstraZeneca
-
Director/PDMR Shareholding
25 September 2025 16:30
AstraZeneca
-
Koselugo recommended for EU approval
22 September 2025 07:05
AstraZeneca
-
Tezspire Recommended for Approval in EU for CRSwNP
22 September 2025 07:00
AstraZeneca
-
Saphnelo met primary endpoint in TULIP-SC
17 September 2025 07:05
AstraZeneca
-
Update on RESOLUTE Phase III trial
17 September 2025 07:00
AstraZeneca
-
Total Voting Rights
1 September 2025 15:00
AstraZeneca
-
Holding(s) in Company
28 August 2025 15:00
AstraZeneca
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.